Graybug Vision Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Graybug Vision Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10690
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Graybug Vision Inc (Graybug Vision) is a clinical stage pharmaceutical company that develops next generation products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company’s lead candidate include GB-102, a clinical-stage depot formulation of sunitinib malatcontains, which is a single small molecule compound that blocks multiple pathogenic angiogenesis pathways included in choroidal neovascularization that causes neovascular or wet age-related macular degeneration. Its pipeline portfolio offers candidates for the treatment of major eye diseases such as glaucoma, retinal vein occlusion, diabetic macular edema, corneal graft rejection, and others. Graybug Vision’s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye. The company operates through its research center located in Baltimore, Maryland, the US. Graybug Vision is headquartered in Redwood City, California, the US.

Graybug Vision Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Graybug Vision Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Graybug Vision Raises USD44.5 Million in Series B Financing 10
GrayBug Raises USD0.7 Million in Financing Round 12
GrayBug Raises USD1.7 Million in Series A2 Financing 13
Graybug Raises USD0.75 Million in Venture Financing 14
Graybug Raises Additional USD0.25 Million in Series A Venture Financing 15
Graybug Raises US$1.2 Million In Venture Financing 16
Licensing Agreements 17
Aerie Pharma Enters into Licensing Agreement with GrayBug 17
GrayBug Enters into Licensing Agreement with Johns Hopkins University 18
Equity Offering 19
GrayBug Raises USD1 Million in Equity Financing 19
Graybug Vision Inc – Key Competitors 20
Graybug Vision Inc – Key Employees 21
Graybug Vision Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Dec 11, 2017: Graybug Vision Expands Executive Leadership Team with Key Hires 23
Jan 03, 2017: Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer 25
Product News 26
08/08/2017: Graybug Vision CEO to Participate in OIS@ASRS Conference 26
Clinical Trials 27
May 08, 2017: Graybug Vision’s Potential Once-Per-Year AMD Treatment Data Presented at ARVO 2017 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Graybug Vision Inc, Pharmaceuticals & Healthcare, Key Facts 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Graybug Vision Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Graybug Vision Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Graybug Vision Raises USD44.5 Million in Series B Financing 10
GrayBug Raises USD0.7 Million in Financing Round 12
GrayBug Raises USD1.7 Million in Series A2 Financing 13
Graybug Raises USD0.75 Million in Venture Financing 14
Graybug Raises Additional USD0.25 Million in Series A Venture Financing 15
Graybug Raises US$1.2 Million In Venture Financing 16
Aerie Pharma Enters into Licensing Agreement with GrayBug 17
GrayBug Enters into Licensing Agreement with Johns Hopkins University 18
GrayBug Raises USD1 Million in Equity Financing 19
Graybug Vision Inc, Key Competitors 20
Graybug Vision Inc, Key Employees 21
Graybug Vision Inc, Subsidiaries 22

List of Figures
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Graybug Vision Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Graybug Vision Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Canadian Solar Inc (CSIQ):企業の財務・戦略的SWOT分析
    Canadian Solar Inc (CSIQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cobalt International Energy, Inc. (CIE)-石油・ガス分野:企業M&A・提携分析
    Summary Cobalt International Energy, Inc. (Cobalt) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets. It has assets in deepwater US Gulf of Mexico and offshore Angola and Gabon in West Africa. The company’s Gulf of Mexico asse …
  • UBM plc:企業のM&A・事業提携・投資動向
    UBM plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UBM plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Cracker Barrel Old Country Store, Inc. (CBRL):企業の財務・戦略的SWOT分析
    Cracker Barrel Old Country Store, Inc. (CBRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • UMW Holdings Bhd (UMW):石油・ガス:M&Aディール及び事業提携情報
    Summary UMW Holdings Bhd (UMW) is a diversified company. The company operates through its business divisions such as automotive, equipment, manufacturing and engineering, and oil and gas. Its automotive business manufactures, assembles, markets and distributes passenger cars and commercial vehicles. …
  • Marksmen Energy Inc (MAH):石油・ガス:M&Aディール及び事業提携情報
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, mines, manages, produces and develops oil and gas properties in Western …
  • ADES International Holding Plc (ADES):企業の財務・戦略的SWOT分析
    ADES International Holding Plc (ADES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Taiheiyo Cement Corporation (5233):企業の財務・戦略的SWOT分析
    Taiheiyo Cement Corporation (5233) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • CSB Bancorp Inc (CSBB):企業の財務・戦略的SWOT分析
    CSB Bancorp Inc (CSBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Orsted AS (DENERG)-石油・ガス分野:企業M&A・提携分析
    Summary Orsted AS (Orsted) formerly Dong Energy A/S is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and o …
  • Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseas …
  • Sony Mobile Communications AB.:企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Telephone and Data Systems, Inc.:企業の戦略・SWOT・財務情報
    Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Centene Corp (CNC)-製薬・医療分野:企業M&A・提携分析
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Golden Valley Mines Ltd. (GZZ):企業の財務・戦略的SWOT分析
    Golden Valley Mines Ltd. (GZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bunge Ltd (BG):企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務情報
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆